Table 1 Clinical and laboratory features on admission
Placebo group | N | LGG group | N | P | |
|---|---|---|---|---|---|
Age (months) | 14.7 ± 6.4 | 89 | 14.9 ± 7.5 | 90 | 0.878 |
Duration of diarrhea before admission (h) | 29.5 ± 14.9 | 89 | 28.8 ± 14.9 | 90 | 0.733 |
N° of stool motions 24 h before admission | 6.6 ± 3.2 | 89 | 7.5 ± 3.9 | 90 | 0.101 |
N° of patients with vomitus 24 h before admission | 64 (71.9%) | 89 | 66 (73.3%) | 90 | 0.963 |
N° of patients with fever 24 h before admission | 39 (43.8%) | 89 | 43 (47.8%) | 90 | 0.703 |
Clinical dehydration | 89 | 90 | 0.165 | ||
Mild | 48 (53.9%) | 36 (40.0%) | |||
Moderate | 40 (44.9%) | 52 (57.8%) | |||
Severe | 1 (1.1%) | 2 (2.2%) | |||
% of weight gain after rehydration | 3.0 ± 2.2 | 89 | 3.1 ± 2.3 | 90 | 0.763 |
Fever at admission (≥ 37.5°C) | 16 (18.0%) | 89 | 14 (15.9%) | 88 | 0.868 |
Weight for height* | 94.8 ± 9.3 | 89 | 94.1 ± 7.6 | 90 | 0.551 |
Height for age* | 88.9 ± 12.1 | 89 | 97.2 ± 3.7 | 90 | 0.546 |
Weight for age* | 88.9 ± 12.1 | 89 | 88.9 ± 10.8 | 90 | 0.952 |
Stool output (ml/kg) first 4 h (rehydration phase) | 14.4 ± 12.4 | 89 | 18.1 ± 16.1 | 90 | 0.085 |
Hematocrit (%) | 35.0 ± 4.2 | 89 | 35.5 ± 3.8 | 90 | 0.426 |
Plasma specific gravity | 1.028 ± 0.002 | 89 | 1.028 ± 0.002 | 90 | 0.769 |
Serum Na+ (mEq/l) | 136.6 ± 4.7 | 89 | 136.4 ± 4.6 | 87 | 0.770 |
Serum K+ (mEq/l) | 4.0 ± 0.7 | 89 | 4.0 ± 0.7 | 87 | 0.985 |
Serum Cl (mEq/l) | 102.5 ± 5.2 | 89 | 102.6 ± 5.4 | 87 | 0.874 |
Serum total CO2 (mmol/l) | 14.0 ± 3.9 | 88 | 14.0 ± 3.9 | 87 | 0.971 |
Blood urea nitrogen (mg/dl) | 13.1 ± 10.5 | 70 | 11.4 ± 6.6 | 73 | 0.253 |
Blood glucose (mg/dl) | 107.5 ± 33.4 | 88 | 106.5 ± 35.9 | 88 | 0.848 |
N° of patients with fecal leukocytes (> 20 PMN/hpf) | 30 (34.5%) | 87 | 21 (23.6%) | 89 | 0.154 |
N° of patients with microscopic fat | 56 (64.4%) | 87 | 52 (58.4%) | 89 | 0.513 |
Fecal pH | 6.3 ± 1.1 | 87 | 6.6 ± 1.1 | 89 | 0.126 |
N° of patients with CHO malabsorption | 39 (45.9%) | 85 | 36 (41.4%) | 87 | 0.659 |